Search Results - "Bao, Loc Carlo"

  • Showing 1 - 4 results of 4
Refine Results
  1. 1
    Binary classification of copy number alteration profiles in liquid biopsy with potential clinical impact in advanced NSCLC

    Binary classification of copy number alteration profiles in liquid biopsy with potential clinical impact in advanced NSCLC by Tosello, Valeria, Grassi, Angela, Rose, Dominic, Bao, Loc Carlo, Zulato, Elisabetta, Dalle Fratte, Chiara, Polano, Maurizio, Del Bianco, Paola, Pasello, Giulia, Guarneri, Valentina, Indraccolo, Stefano, Bonanno, Laura

    Published in Scientific reports (09-08-2024)
    “…Liquid biopsy has recently emerged as an important tool in clinical practice particularly for lung cancer patients. We retrospectively evaluated cell-free DNA…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  2. 2
    Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reports

    Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reports by Bao, Loc Carlo, Padovan, Alessia, Boscolo Bragadin, Andrea, Calvetti, Lorenzo, Guarneri, Valentina, Bonanno, Laura, Indraccolo, Stefano

    Published in Frontiers in oncology (11-03-2024)
    “…Epidermal Growth Factor Receptor (EGFR) and B-Raf (BRAF) mutations are two of the most important drivers identified in non-small-cell lung cancer (NSCLC). This…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  3. 3
    Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis

    Real-world impact of the introduction of chemo-immunotherapy in extended small cell lung cancer: a multicentric analysis by Bonanno, Laura, Calvetti, Lorenzo, Dal Maso, Alessandro, Pavan, Alberto, Bao, Loc Carlo, De Nuzzo, Mattia, Frega, Stefano, Sartori, Giulia, Ferro, Alessandra, Pasello, Giulia, Morandi, Paolo, Aprile, Giuseppe, Guarneri, Valentina

    Published in Frontiers in immunology (2024)
    “…Recent clinical trials demonstrated longer survival in extended small cell lung cancer (SCLC) patients treated with immunotherapy in addition to chemotherapy…”
    Get full text
    Journal Article
    Save to List
    Saved in:
  4. 4
    Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reports

    Efficacy of osimertinib and the role of sequential liquid biopsy in patients diagnosed with NSCLC harboring EGFR and BRAF mutations at baseline: insights from two case reports by Bao, Loc Carlo, Padovan, Alessia, Boscolo Bragadin, Andrea, Calvetti, Lorenzo, Guarneri, Valentina, Bonanno, Laura, Indraccolo, Stefano

    Published in Frontiers in oncology (01-01-2024)
    “…Epidermal Growth Factor Receptor (EGFR) and B-Raf (BRAF) mutations are two of the most important drivers identified in non-small-cell lung cancer (NSCLC). This…”
    Get full text
    Report
    Save to List
    Saved in:

Search Tools: